Halozyme Therapeutics Inc. (HALO)

$ 76.90
   
  • Change Today:
    $-0.63
  • 52 Week High: $77.60
  • 52 Week Low: $42.57
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 1,121,532
  • Market Cap: $11,174m
  • RiskGrade: 189

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,320.08 826.35 616.50¢ 12.5 n/a n/a n/a 0.0%
31-Dec-26 1,626.20 1,080.66 796.60¢ 9.7 0.3 +29% n/a 0.0%
31-Dec-27 1,910.54 1,364.11 978.50¢ 7.9 0.3 +23% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 76.90
Change Today $ -0.63
% Change -0.81 %
52 Week High $77.60
52 Week Low $42.57
Volume 1,121,532
Shares Issued 145.30m
Market Cap $11,174m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 3
Sell 1
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 12-Sep-2025

Time Volume / Share Price
16:00 176,365 @ $76.90
15:59 200 @ $76.88
15:59 100 @ $76.89
15:59 190 @ $76.68
15:59 100 @ $76.88

Top of Page